Data protection Impressum

R&D

This funding follows closely on the heels of the completion of enrollment of Spineart’s BAGUERA® C Intervertebral Disc (IDE) studies, which aim to push the boundaries of spinal surgery through extensive research and development efforts.

Spineart raises CHF 20 million to push the boundaries of spinal surgery

20 March 2024

The project, "La Pendule," conceptualized by Losinger Marazzi SA and IPAS Architects, has been selected for its emblematic representation of innovation, standing as the final piece in the puzzle of Neuchâtel’s innovative ecosystem.

Neuchâtel’s innovation hub expands with groundbreaking JD7 building

12 March 2024

CSEM and ClexBio, a Nordic startup specializing in regenerative medicine, has developed a novel bioreactor capable of cultivating human veins in the laboratory.

CSEM and ClexBio unveil groundbreaking bioreactor to advance cardiovascular treatment

26 February 2024

This alliance between Atinary and Takeda is a shining example of how technology and healthcare can come together to create innovative solutions that address pressing challenges in drug development.

Atinary and Takeda forge a strategic alliance to advance healthcare innovation

19 February 2024

This strategic program aims to fortify Swiss research and innovation in semiconductor technologies, microelectronics, and integrated circuit (IC) design.

Switzerland launches the SwissChips initiative to strengthen the domestic semiconductor industry

14 February 2024

Eric Grenet (left) and Edoardo Franzi (right) were presented with the "CSEM Inventor Award 2024" for their invention of "spaceCoder technology", which they developed together with former CSEM employees David Hasler and Peter Masa.

CSEM’s “spaceCoder” precision measurement technology wins Inventor Award 2024

7 February 2024

Nicolas Collin, Co-Founder and CEO of the Vaccine Formulation Institute (VFI), discusses the innovative approach and global impact of their work in developing high-quality, accessible adjuvants for vaccines and why Geneva was chosen as the ideal location for VFI's impactful work.

Why the Vaccine Formulation Institute chose Western Switzerland

23 January 2024

STALICLA has developed the first neurodevelopmental disorder-specific precision medicine platform with an initial application in autism spectrum disorder (ASD).

STALICLA secures USD 17.4 million to propel neuro precision medicine

22 January 2024

Eversys uses AI for predictive maintenance in coffee machines.

Eversys’ AI use for enhanced innovation in coffee machine production

16 January 2024

This funding and partnership with the ADDF place GliaPharm at the forefront of developing effective treatments for Alzheimer’s, offering new hope in the fight against this challenging neurodegenerative disease.

GliaPharm receives USD 4.2 million to propel Alzheimer’s treatment development

20 December 2023

1 … 5 6 7 8 9 10 11 12 13 … 16